4.4 Dispensing Operations: Interchangeability, Adjudication, Compliance Packaging, Release & Inventory Control

Dispensing Operations: Interchangeability, Adjudication, Compliance Packaging, Release & Inventory Control

About 20% of Part I items come from the Distribution domain (competencies 1.6 to 1.10). Many of these are not about compounding or calculations. They test the daily operational decisions that keep dispensing safe and lawful: which product may be substituted, how a claim is adjudicated, what goes into a compliance pack, how a prescription is released, and how inventory, including controlled substances, is reconciled. This section brings those operations together.

---

1. Interchangeability and Generic Substitution

Health Canada authorizes a generic through an Abbreviated New Drug Submission that shows bioequivalence to the Canadian Reference Product (section 1.1). Whether a pharmacist may substitute one product for another, however, is a provincial matter:

• Interchangeability lists: each province publishes a formulary or list of interchangeable products (for example, Ontario's Formulary/Comparative Drug Index). Substitution is allowed only between products listed as interchangeable.
• Prescriber "no substitution": when the prescriber writes "no substitution" (or the provincial equivalent), the pharmacist dispenses the brand prescribed. Public plans often reimburse only the lowest-cost interchangeable product, so the patient may pay the difference.
• Patient choice: a patient may decline a generic and pay the difference where plan rules allow.
• Narrow-therapeutic-index drugs: substitution is lawful between listed interchangeable products, but switching manufacturers back and forth for drugs such as levothyroxine, warfarin, antiepileptics or cyclosporine warrants monitoring (TSH, INR, levels) and counselling.
• Biosimilars are not generics. They are not automatically interchangeable at the pharmacy counter. Switching happens through provincial biosimilar policies or a new prescription (section 17.3).

---

2. Third-Party Adjudication and Drug Utilization Review

Most Canadian prescriptions are adjudicated online in real time to a payer: a provincial public plan, the federal Non-Insured Health Benefits (NIHB) program for eligible First Nations and Inuit clients, Veterans Affairs, or a private insurer. Key points:

• Claim rejections carry codes such as "refill too soon", "drug not a benefit", "special authorization required" or "maximum quantity exceeded". A rejection is a prompt to investigate, never a reason to falsify days' supply or quantities. Billing a false days' supply to get around a refill-too-soon edit is fraud.
• Drug utilization review (DUR) alerts from provincial networks (for example, drug interaction, duplicate therapy, or multiple-prescriber flags) must be assessed and documented. An intervention code is entered only after the pharmacist has actually resolved the issue.
• Coordination of benefits: when a patient has two plans, the primary payer is billed first and the balance is submitted to the secondary plan.
• Special or exception authorization (for example, for biologics) needs prescriber documentation. The pharmacist can help by identifying criteria and coverage alternatives.

---

3. Prescription Transfers, Part-Fills and Balances Owing

• Non-controlled prescriptions are transferred under provincial rules. The receiving pharmacy records the transferring pharmacy, the original prescription details, remaining refills, and the dates.
• Controlled substances may be transferred by a pharmacist or a pharmacy technician within 2 years of the original receipt, with the written prescription or verbal-prescription record. The transfer is documented by both sides (CSR s. 102 and s. 119).
• Part-fills and "owes": when stock is short, the pharmacy dispenses part of the quantity and records a balance owing. During a controlled-substance count, balances owing are tablets that are legitimately still on the shelf. They must be accounted for before a shortage is called a loss.

---

4. Compliance Packaging (Blister and Pouch Packs)

Multi-drug compliance packaging improves adherence for patients with complex regimens or cognitive impairment, but it is a form of repackaging:

---

5. Releasing the Prescription

The final step is where wrong-patient errors are caught or missed:

• Confirm identity with two identifiers, for example the patient's address and date of birth. Do not simply ask "Are you Mr. Smith?", because anxious or hard-of-hearing patients often say yes. PEBC's sample items use address plus date of birth.
• Check the bag against the profile: right patient, right drugs, right number of items.
• Counsel on new prescriptions and changes, and ask open-ended questions for refills ("How are you taking it?").
• Controlled substances are released by the pharmacist (CSR s. 98). Pickup by an agent and delivery must follow provincial policy, and any delivery must be secure and trackable (CSR s. 107).

---

6. Inventory Management, Returns and Disposal

• Rotation: first-expiry, first-out. Check expiry dates on a schedule, and quarantine expired stock until it is returned or destroyed.
• Cold chain: refrigerated products are stored at 2 to 8°C with continuous or twice-daily temperature logging. Excursions are quarantined and evaluated with the manufacturer (section 4.3).
• Recalls: quarantine affected lots, identify patients, and document the response (section 1.1).
• Returned medications are never re-dispensed once they have left the pharmacy, because storage conditions and tampering cannot be verified. Patient returns go to the disposal stream. Industry take-back programs, such as those run by the Health Products Stewardship Association in several provinces, collect unused medications from community pharmacies.
• Returned controlled substances go into a secure, marked collection container. They are then destroyed in the pharmacy with a witness and joint declaration, or sent to a licensed dealer specialized in destruction (CSR s. 104 and s. 110).

---

7. Controlled-Substance Reconciliation

Regular counts compare the expected inventory (opening balance + receipts − dispensed − destroyed − transferred) with the physical count. When they differ:

1. Recount and confirm the expected figure.
2. Look for paper explanations first: unrecorded receipts, prescriptions entered in the wrong strength or product, balances owing, returns to supplier, and destruction not yet recorded.
3. Review high-risk patterns: voided or reversed transactions, unusual part-fills, and access logs.
4. If the shortage remains unexplained, treat it as a loss. Report it in writing to Health Canada within 10 days (CSR s. 109), notify police if theft is suspected, and inform the provincial college if its standards require it.
5. Never adjust the count to match the expected figure without finding the cause.